Systems Biology enabled individualized risk assessment and therapy matching.
A systems approach will enable “patient-centric” paradigm for personalized, precision oncology.
Sygnomics uses SYstems Genetic Network AnaLysis (SYGNAL) technology to accurately predict risk of disease progression and rank prioritize therapies that target specific cancer-driving gene networks in an individual patient.